Lynch Syndrome: Identification and Risk Assessment Strategies - Session 1
Dana-Farber Cancer Institute via YouTube
Overview
Learn about Lynch syndrome identification and risk assessment through a comprehensive medical lecture series featuring expert presentations on the PREMM Model's development, identification strategies for diverse populations, population-based approaches, and health systems-based identification methods. Explore detailed insights from leading medical professionals, including Dr. Fay Kastrinos's discussion of the PREMM Model applications, Dr. Elena Stoffel's examination of Lynch syndrome identification in marginalized communities, Dr. Sigurdis Haraldsdottir's analysis of population-based identification approaches in Iceland, and Dr. Alanna Kulchak Rahm's overview of health systems-based identification strategies. Gain valuable knowledge through these lectures and participate in an interactive panel Q&A session that addresses key aspects of Lynch syndrome care and identification protocols.
Syllabus
Session 1: Identification and Risk Assessment
Taught by
Dana-Farber Cancer Institute